Chordate Medical Holding AB (publ) announced that the European Patent Office has granted Chordate's patent application EP 20163024.1 from 2020. The patent application pertains to the company's treatment technique Ozilia, especially targeting chronic migraine. Chordate Medical now holds 78 patents distributed across 9 patent families, providing protection for various aspects of the company's treatment techniques in 32 countries/regions.

The granting and validation of application EP 20163024. 1 mean that additional patents have been added to a growing portfolio that the company began building in 2008.